Clinical Trial Update: Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

View source ↗

Summary

A completed surveillance study to estimate the incidence of pure red cell aplasia in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Pure Red Cell Aplasia

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Pure Red-Cell Aplasia, Chronic Kidney Failure | Status: COMPLETED